📰 Bvf Inc News
Bvf Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bvf Inc. Real-time updates on events, politics, business and more.
December 11, 2023
BVF Inc. IL lowered its holdings in shares of Verastem, Inc. (NASDAQ:VSTM – Free Report) by 91.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,685,219 shares of the biopharmaceutical company’s stock after selling 17,337,437 shares during the period. BVF Inc. IL owned […]
December 11, 2023
BVF Inc. IL increased its stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 26.2% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,255,588 shares of the company’s stock after buying an additional 1,300,000 shares during the period. Revolution Medicines accounts for about […]
December 11, 2023
BVF Inc. IL bought a new position in shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN – Free Report) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 1,049,999 shares of the company’s stock, valued at approximately $3,832,000. BVF Inc. IL owned approximately 0.06% of ASLAN Pharmaceuticals as of its most recent SEC filing. A number […]
December 11, 2023
BVF Inc. IL lifted its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 11.1% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,846,015 shares of the company’s stock after acquiring an additional 285,254 shares during […]
December 11, 2023
BVF Inc. IL boosted its holdings in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 23.8% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 19,995,332 shares of the biopharmaceutical company’s stock after buying an additional 3,846,153 shares during the period. Lexicon Pharmaceuticals makes up approximately 1.3% of BVF Inc. IL’s […]
December 11, 2023
BVF Inc. IL acquired a new position in shares of Delcath Systems, Inc. (NASDAQ:DCTH – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,178,787 shares of the company’s stock, valued at approximately $6,872,000. BVF Inc. IL owned 11.10% of Delcath Systems […]
October 18, 2022
Relmada shares tumbled more than 75% on Thursday after the biotechnology company said its most promising drug failed in late stage testing.